Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zealand Pharma A/S ADR (ZEAL)

Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zealand Pharma A/S ADR SYDMARKEN 11 COPENHAGEN G7 2860 DNK

www.zealandpharma.com P: 45-8877-3600 F: +45 88773898

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 818,603
Enterprise Value, $K 694,463
Shares Outstanding, K 46,538
Float, K 45,514
% Float 97.80%
Short Volume Ratio 0.99
% of Insider Shareholders 2.20%
% of Institutional Shareholders 1.73%
Annual Net Income, $ -161,990 K
Last Quarter Sales, $ 4,060 K
Last Quarter Net Income, $ -69,960 K
3-Year Return -29.50%
5-Year Return -5.94%
5-Year Revenue Growth 33.42%
5-Year Earnings Growth -302.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.40 on 08/11/22
Next Earnings Date 11/10/22
Earnings Per Share ttm -3.76
EPS Growth vs. Prev Qtr -122.22%
EPS Growth vs. Prev Year -26.13%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ZEAL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -111.05%
Return-on-Assets % -56.54%
Profit Margin % -347.99%
Debt/Equity 0.93
Price/Sales 17.38
Price/Cash Flow N/A
Price/Book 7.17
Book Value/Share 0.00
Interest Coverage -64.10
60-Month Beta 1.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar